A Consumer-First Healthcare Vision — Anne Wojcicki, CEO 23andMe

The Industrialist’s Dilemma — January 28, 2016

The Customer Isn’t Always the Customer

During class, Anne mentioned being at a healthcare conference early in her career where the subject of conversation was medicare billing rates. Hordes of people descended to discuss how much they could bill back to the government and to insurers — smart people, who otherwise might be able to use their collective brainpower to solve the actual problems of their consumer.

With the Right Information, New Revenues Can Be Added Later

23andMe’s focus was to offer value back to consumers through genetic screening. Understanding your own genome could provide patients much needed reasons to get extra exercise, change their diets, and avoid potentially hazardous behaviors.

Sometimes the Reaction to Innovation Is Unexpected

The last takeaway we had was that sometimes the impact of your disruption is non-obvious. Early in the class, we asked our students who 23andMe would impact most dramatically. The responses favored the existing drug development companies. If Anne can capture enough data, then why can’t she be able to simply build the next great pharmaceutical business.



A course at the Stanford Graduate School of Business taught by Stanford Lecturer and venture investor Robert Siegel (@robsiegel) and SAP EVP & Chief Learning Officer Max Wessel (@maxwellelliot)

Get the Medium app

A button that says 'Download on the App Store', and if clicked it will lead you to the iOS App store
A button that says 'Get it on, Google Play', and if clicked it will lead you to the Google Play store
Maxwell Wessel

Chief Learning Officer @SAP. Faculty @Stanford. Lucky recipient of great friends and brilliant colleagues.